Literature DB >> 8995361

Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation.

L A Marshall1, B Bolognese, J D Winkler, A Roshak.   

Abstract

Human monocytes possess several acylhydrolase activities and are capable of producing both prostanoids (PG) and leukotriene (LT) products upon acute stimulation with calcium ionophore, A23187 or phagocytosis of zymosan particles. The cytosolic 85-kDa phospholipase (PLA) A2 co-exists with the 14-kDa PLA2 in the human monocyte, but their respective roles in LT production are not well understood. Reduction in 85-kDa PLA2 cellular protein levels by initiation site-directed antisense (SK 7111) or exposure to the 85-kDa PLA2 inhibitor, arachidonyl trifluoromethyl ketone (AACOCF3), prevented A23187 or zymosan-stimulated monocyte prostanoid formation. In contrast, neither treatment altered stimulated LTC4 production. This confirmed the important role of the 85-kDa PLA2 in prostanoid formation but suggests that it has less of a role in LT biosynthesis. Alternatively, treatment of monocytes with the selective, active site-directed 14-kDa PLA2 inhibitor, SB 203347, prior to stimulation had no effect on prostanoid formation at concentrations that totally inhibited LT formation. Addition of 20 microM exogenous arachidonic acid to monocytes exposed to SK 7111 or SB 203347 did not alter A23187-induced PGE2 or LTC4 generation, respectively, indicating that these agents had no effect on downstream arachidonic acid-metabolizing enzymes in this setting. Taken together, these results provide evidence that the 85-kDa PLA2 may play a more significant role in the formation of PG than LT. Further, utilization of SB 203347 provides intriguing data to form the hypothesis that a non-85-kDa PLA2 sn-2 acyl hydrolase, possibly the 14-kDa PLA2, may provide substrate for LT formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995361     DOI: 10.1074/jbc.272.2.759

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells.

Authors:  H Fujishima; R O Sanchez Mejia; C O Bingham; B K Lam; A Sapirstein; J V Bonventre; K F Austen; J P Arm
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Pasteurella haemolytica leukotoxin-induced increase in phospholipase A2 activity in bovine neutrophils.

Authors:  Z Wang; C Clarke; K Clinkenbeard
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Interleukin-6 production by activated human monocytic cells is enhanced by MK-571, a specific inhibitor of the multi-drug resistance protein-1.

Authors:  E Vellenga; L Tuyt; B J Wierenga; M Müller; W Dokter
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.

Authors:  P García Pastor; S De Rosa; A De Giulio; M Payá; M J Alcaraz
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2.

Authors:  P N Bernatchez; M V Winstead; E A Dennis; M G Sirois
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

6.  Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness.

Authors:  Teal S Hallstrand; Emil Y Chi; Alan G Singer; Michael H Gelb; William R Henderson
Journal:  Am J Respir Crit Care Med       Date:  2007-09-27       Impact factor: 21.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.